Angelo Scopelianos, Chief R&D Officer at Axogen, Inc. (AXGN), sold 6,881 shares at $7.68 ($53K) on 2024-03-21, disclosed to the SEC on 2024-03-25.
Open-market sale of $53k AXGN by Chief R&D Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.68 | 610 | $5K | 8.9% |
| 2 | $7.68 | 1,020 | $8K | 14.8% |
| 3 | $7.68 | 5,251 | $40K | 76.3% |
| Total | $7.68 avg | 6,881 | $53K | 100% |